Skip to main content
. 2021 Nov 26;22:e932961-1–e932961-7. doi: 10.12659/AJCR.932961

Figure 2.

Figure 2.

Liver function test (LFT) values in a graph showing rapidly increasing LFTs in the acute phase of non-alcoholic steatohepatitis and decreasing after PCSK9 inhibitor treatment.